Ireland
--:--IST
Recruiting Observational

Automated Ultrasound Cardiac Guidance Tool

NCT05649826 · tracked via the Priya Life Science USA tracker
Sponsor
UltraSight
Phase
Observational
Started
2023-02-01
Last updated
2024-05-21

Condition(s) studied

Ultrasound Imaging

Study summary

This research examines echocardiography images taken from cardiac patients in relation to the guidance tool developed

Eligibility

Sex
ALL
Min age
18 Years
Max age
120 Years
Healthy volunteers
No
Inclusion Criteria: 1. Males and females, aged 18 years and older 2. Subject willing and able to give written informed consent Exclusion Criteria: 1. Emergency (non-elective) admission within 24 h prior to participating in the study 2. Female subjects who are pregnant (women of childbearing potential will provide a statement that they are not pregnant incorporated in the ICF 3. Unable to lie as required in all the classic positions for standard TTE exam: supine on back / left decubitus 4. Subjects who currently participate in a clinical trial, involving interventional cardiac devices. 5. Subjects who have prior Echo exam with description of Low/Poor quality exam in the echo report. 6. Subjects with BMI above 40. 7. Subjects experiencing a known or suspected acute cardiac event. 8. Subjects with severe chest wall deformity as per previous medical records and physical examination. 9. Subjects who have undergone pneumonectomy. 10. Subjects whose anatomy does not lend itself to yield diagnosable standard echocardiography clips (i.e., situs inversus with dextrocardia, single ventricle anatomy due to congenital heart disease, etc.).

Primary outcome measure(s)

  • Acquisition of transthoracic echocardiography media from up to 200 subjects — up to 5 year
    Several echocardiography views will be acquired from the participants, with in several acoustic windows and views

Trial sites (1)

FacilityCityRegionStatus
Wayne University Detroit Michigan Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05649826 on ClinicalTrials.gov ↗ ← All trials in the USA